Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective. - Wikidata - awgldk - TriplyDB

Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective.

Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective.

http://www.wikidata.org/entity/Q39272183

about

Syk inhibitors in clinical development for hematological malignancies.Building a Safer and Faster CAR: Seatbelts, Airbags, and CRISPR.Posttransplant chimeric antigen receptor therapy.The dawn of vaccines for cancer prevention.Current Status of Gene Engineering Cell Therapeutics.Towards 'off-the-shelf' genetically modified T cells: prolonging functional engraftment in mice by CD8 veto T cells.Emerging applications of gene edited T cells for the treatment of leukemia.Long Terminal Repeat CRISPR-CAR-Coupled "Universal" T Cells Mediate Potent Anti-leukemic Effects.Myeloid Conditioning with c-kit-Targeted CAR-T Cells Enables Donor Stem Cell Engraftment.Therapeutic Potential of Gene-Modified Regulatory T Cells: From Bench to Bedside.TGF-β in T Cell Biology: Implications for Cancer Immunotherapy.Self-Delivering RNAi Targeting PD-1 Improves Tumor-Specific T Cell Functionality for Adoptive Cell Therapy of Malignant Melanoma Recombination of a dual-CAR-modified T lymphocyte to accurately eliminate pancreatic malignancy generation of human CD19-CAR T cells results in B-cell depletion and signs of cytokine release syndrome

P2860

Q42011012-00113CC0-68A4-45BF-BCD2-A51DA8908169 Q47443955-25998D87-BC02-4703-8E14-2891C4DFEDD6 Q47550219-4BE5FD95-8423-470A-BFCC-36A162518109 Q49566629-EF482C4E-3FD0-42E0-B766-00E757AB86EA Q49829282-EA9A29F6-4E5B-407B-86F1-780C9EB9E828 Q49900872-2646B4DB-AA01-4FC3-8319-9A241C47DB8C Q50029336-5A3271E2-2735-4B74-8643-7265D7951E60 Q52431202-62D2FBA6-1299-4F9D-A2D0-D388C4691685 Q52603959-EB2F99F9-F267-4E83-872A-B3860E39DD36 Q52674851-B0A69B49-7759-4485-8128-278F54CC5E3C Q55515390-3CD3D13C-8BA5-45FB-8AD7-4AA12ADC691F Q56891950-F3250F41-3951-4E33-8320-DE5FFAF455BF Q58786421-C148FFCF-AD6C-4CCA-8EFC-EB8608B0DE4F Q59137796-7364D334-C8B7-46BF-89E8-E7EF202C758C

P2860

Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective.

http://www.wikidata.org/entity/Q39272183

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective.

@en

Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective.

@nl

type

label

Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective.

@en

Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective.

@nl

prefLabel

Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective.

@en

Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective.

@nl

P1433

Q39272183-210DB188-295D-443F-917D-EA9CAC5DB343

P1476

Q39272183-06806162-4C55-48F5-A72A-48C86E2DD69E

P2093

Q39272183-A55F9D4C-9050-47B1-8391-F57F36AF0A5E

Q39272183-DF023F88-407F-4501-A2C2-DA0E1300D586

P2860

Q39272183-0002EC7E-9729-45A6-93E9-E840F09C2BB4

Q39272183-0150583D-A2F2-41D5-97E6-5DA552575840

Q39272183-01D078B6-80F9-4484-B25A-2329CD85581E

Q39272183-01D34204-29DC-46CD-9FDD-26DBC1A9610C

Q39272183-05F912D2-6013-4072-A592-18B836637259

Q39272183-0729237C-93BD-4109-B539-08FA69B576EB

Q39272183-07995CEB-EFB3-4D05-8F3B-312EE3B8201B

Q39272183-08E29E80-671B-4341-BBDD-6AD4EBFAB44E

Q39272183-0E399A9F-0C36-4EE8-B55B-D1DAEA27645B

Q39272183-0EFFC78A-B959-4A17-9D65-4BE5D7B092CA

P304

Q39272183-C9649696-1F37-44F6-84BF-02920B829EBF

P31

Q39272183-EE8DCDA0-50FD-4526-97B3-349BD28E74DC

P356

Q39272183-E06FC81C-7BD4-40FC-9C06-1447202172AC

P433

Q39272183-406E7759-4EF3-49AC-BD75-92225252D781

P478

Q39272183-98B23B70-80A6-494C-B982-C092B63ED26A

P577

Q39272183-1A842780-0A4C-41D7-9731-4A668A1C0541

P698

Q39272183-EE2A9F46-ACE3-47B0-92CE-C3A5BD012ACA

P921

Q39272183-3553CE75-2877-4DA7-A8D4-DD79C2667867

P932

Q39272183-E2F638D1-0200-40C9-8CAE-DC60C73D08C6

P356

J.YMTHE.2017.03.034

P1433

Molecular Therapy

P1476

Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective.

@en

P2093

Isabelle Rivière

http://www.w3.org/2001/XMLSchema#string

Michel Sadelain

http://www.w3.org/2001/XMLSchema#string

P2860

CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors

Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells

Cancer regression in patients after transfer of genetically engineered lymphocytes

Gene transfer in humans using a conditionally replicating lentiviral vector

Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences

Clinical manufacturing of CAR T cells: foundation of a promising therapy

Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors

A new approach to gene therapy using Sleeping Beauty to genetically modify clinical-grade T cells to target CD19

P304

1117-1124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YMTHE.2017.03.034

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28456379

http://www.w3.org/2001/XMLSchema#string

P921

P932

5417838

http://www.w3.org/2001/XMLSchema#string